Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MAPKAPK3

RBC: MAPKAPK3 · Substrate: Glycogen Synthase-derived peptide ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Dasatinib18.60.70
Repotrectinib17.70.61
Afatinib15.20.71
Tivozanib14.90.67
Bosutinib14.80.55
Midostaurin14.40.50
Regorafenib11.50.72
Ruxolitinib11.40.59
Umbralisib11.20.67
Erlotinib10.70.69
Gilteritinib10.50.51
Nintedanib10.40.61
Lapatinib10.00.62
Axitinib9.90.69
Brigatinib9.80.51

Known variants

No variants catalogued.
Open in new tab